What is the price-to-earnings ratio of Flexion Therapeutics?
The price-earnings ratio of Flexion Therapeutics is currently 1.39.
Flexion Therapeutics P/S 2024
Flexion Therapeutics P/S
1.39
Flexion Therapeutics Dividend yield
Ticker
FLXN
ISIN
US33938J1060
WKN
A1XEDR
As of Jun 1, 2024, Flexion Therapeutics's P/S ratio stood at 1.39, a 0% change from the 0 P/S ratio recorded in the previous year.
The Flexion Therapeutics P/S history
Flexion Therapeutics Aktienanalyse
What does Flexion Therapeutics do?
Flexion Therapeutics is a biotechnology company specializing in the development and marketing of drugs for the treatment of pain and inflammation. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. Flexion Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Flexion Therapeutics's P/S Ratio
Flexion Therapeutics's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Flexion Therapeutics's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Flexion Therapeutics's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Flexion Therapeutics’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Flexion Therapeutics Stock
How has the price-earnings ratio of Flexion Therapeutics changed compared to last year?
The price-to-earnings ratio of Flexion Therapeutics has increased by 0% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Flexion Therapeutics high compared to other companies?
Yes, the price-to-earnings ratio of Flexion Therapeutics is high compared to other companies.
How does an increase in the price-earnings ratio of Flexion Therapeutics affect the company?
An increase in the price-earnings ratio of Flexion Therapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Flexion Therapeutics affect the company?
A decrease in the price-earnings ratio of Flexion Therapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Flexion Therapeutics?
Some factors that influence the price-earnings ratio of Flexion Therapeutics are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Flexion Therapeutics pay?
Over the past 12 months, Flexion Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Flexion Therapeutics is expected to pay a dividend of 0 USD.
What is the dividend yield of Flexion Therapeutics?
The current dividend yield of Flexion Therapeutics is .
When does Flexion Therapeutics pay dividends?
Flexion Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Flexion Therapeutics?
Flexion Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Flexion Therapeutics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Flexion Therapeutics located?
Flexion Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Flexion Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Flexion Therapeutics from 6/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2024.
When did Flexion Therapeutics pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Flexion Therapeutics in the year 2023?
In the year 2023, Flexion Therapeutics distributed 0 USD as dividends.
In which currency does Flexion Therapeutics pay out the dividend?
The dividends of Flexion Therapeutics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Flexion Therapeutics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Flexion Therapeutics
Our stock analysis for Flexion Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Flexion Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Flexion Therapeutics Revenue
- Flexion Therapeutics Net Income
- Flexion Therapeutics P/E
- Flexion Therapeutics P/S
- Flexion Therapeutics EBIT
- Flexion Therapeutics Dividend
- Flexion Therapeutics Stocks
- Flexion Therapeutics Market capitalization
- Flexion Therapeutics Debt
- Flexion Therapeutics Liabilities
- Flexion Therapeutics Equity
- Flexion Therapeutics AAQS
- Flexion Therapeutics Employees
- Flexion Therapeutics ROE
- Flexion Therapeutics ROA
- Flexion Therapeutics ROCE
